Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Assisted Reproduction and Genetics
Published in: Journal of Assisted Reproduction and Genetics 11/2018

01-11-2018 | Fertility Preservation

Oocyte cryopreservation among transmasculine youth: a case series

Authors: Diane Chen, Lia A. Bernardi, Mary Ellen Pavone, Eve C. Feinberg, Molly B. Moravek

Published in: Journal of Assisted Reproduction and Genetics | Issue 11/2018

Login to get access

Excerpt

Approximately 150,000 youth (ages 13–17) in the USA identify as transgender [1]. Transgender people frequently experience gender dysphoria, which refers to the affective distress that stems from incongruence between an individual’s assigned sex at birth and their gender identity [2]. Many transgender people seek gender-affirming hormone therapy (i.e., testosterone or estrogen) or surgery as a means to decrease gender dysphoria by bringing their bodies and gender identities into alignment. While these interventions are effective in reducing gender dysphoria and improving psychosocial functioning [3], many of the surgical procedures are sterilizing, and the long-term effects of gender-affirming hormones on reproductive function are unknown. …
Literature
1.
2.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. fifth ed. Arlington: American Psychiatric Association; 2013.CrossRef
3.
Costa R, Colizzi M. The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: a systematic review. Neuropsychiatr Dis Treat. 2016;12:1953–66.CrossRef
4.
De Roo C, Tilleman K, T' Sjoen G, De Sutter P. Fertility options in transgender people. Int Rev Psychiatry. 2016;28:112–9.CrossRef
5.
Wierckx K, Van Caenegem E, Pennings G, Elaut E, Dedecker D, et al. Reproductive wish in transsexual men. Hum Reprod. 2012;27:483–7.CrossRef
6.
De Sutter P, Kira K, Verschoor A, Hotimsky A. The desire to have children and the preservation of fertility in transsexual women: a survey. Int J Transgenderism. 2002;6:215–21.
7.
Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism. 2012;13:165–232.CrossRef
8.
Ethics Committee of the American Society of Reproductive Medicine. Access to fertility services by transgender persons: an ethics committee opinion. Fertil Steril. 2015;104:1111–5.CrossRef
9.
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:3869–903.CrossRef
10.
Spack NP, Edwards-Leeper L, Feldman HA, Leibowitz S, Mandel F, Diamond DA, et al. Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics. 2012;129:418–25.CrossRef
11.
Hsieh S, Leininger J. Resource list: clinical care programs for gender-nonconforming children and adolescents. Pediatr Ann. 2014;43:238–44.CrossRef
12.
Chen M, Fuqua J, Eugster EA. Characteristics of referrals for gender dysphoria over a 13-year period. J Adolesc Health. 2016;58:369–71.CrossRef
13.
Oktay K, Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. J Pediatr Adolesc Gynecol. 2014;27:342–6.CrossRef
14.
Reichman DE, Davis OK, Zaninovic N, Rosenwaks Z, Goldschlag DE. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril. 2012;98:1225–8.CrossRef
15.
Lavery SA, Islam R, Hunt J, Carby A, Anderson RA. The medical and ethical challenges of fertility preservation in teenage girls: a case series of sickle cell anaemia patients prior to bone marrow transplant. Hum Reprod. 2016;31:1501–7.CrossRef
16.
Dovey S, Krishnamurti L, Sanfilippo J, Gunawardena S, Mclendon P, Campbell M, et al. Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report. J Assist Reprod Genet. 2012;29(3):265–9.CrossRef
17.
Noyes N, Perretta RC, Fino ME, Matulewicz T, Barakat R. Use of hormone suppression then oocyte freezing to preserve reproductive capability in an adolescent girl with ovarian luteinized thecoma associated with sclerosing peritonitis. Fertil Steril. 2009;92(1):393.e11–4.CrossRef
18.
Kim TJ, Hong SW. Successful live birth from vitrified oocytes after 5 years of cryopreservation. J Assist Reprod Genet. 2011;28:73–6.CrossRef
19.
Kutteh WH, Klosky JL, Green DM, Sparrow CK, Kutteh MA, Robinson GW, et al. Ovulation induction and oocyte retrieval for fertility preservation in young adolescents newly diagnosed with medulloblastoma: a case series. J Obstet Gynaecol. 2018;38(6):878–9.CrossRef
20.
Chen D, Matson M, Macapagal K, Johnson EK, Rosoklija I, Finlayson C, et al. Attitudes toward fertility and reproductive health among transgender and gender-nonconforming adolescents. J Adolesc Health. 2018;63(1):62–8.CrossRef
21.
Armuand G, Dhejne C, Olofsson JI, Rodriguez-Wallberg KA. Transgender men’s experiences of fertility preservation: a qualitative study. Hum Reprod. 2017;32:383–90.CrossRef
22.
Finlayson C, Johnson EK, Chen D, Dabrowski E, Gosiengfiao Y, Campo-Engelstein L, et al. Proceedings of the working group session on fertility preservation for individuals with gender and sex diversity. Transgend Health. 2016;1:99–107.CrossRef
23.
Lierman S, Tilleman K, Braeckmans K, Peynshaert K, Weyers S, T’Sjoen G, et al. Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles. J Assist Reprod Genet. 2017;34:1449–56.CrossRef
24.
De Roo C, Lierman S, Tilleman K, Peynshaert K, Braeckmans K, Caanen M, et al. Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment. Reprod Biomed Online. 2017;34(6):557–66.CrossRef
25.
Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab. 1986;62:16–21.CrossRef
26.
Ikeda K, Baba T, Noguchi H, Nagasawa K, Endo T, Kiya T, et al. Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Hum Reprod. 2013;28:453–61.CrossRef
27.
Pache TD, Chadha S, Gooren LJ, Hop WC, Jaarsma KW, et al. Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology. 1991;19:445–52.CrossRef
28.
Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, et al. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab. 1989;69:151–7.CrossRef
29.
Van Den Broecke R, Van Der Elst J, Liu J, Hovatta O, Dhont M. The female-to-male transsexual patient: a source of human ovarian cortical tissue for experimental use. Hum Reprod. 2001;16:145–7.CrossRef
30.
Grynberg M, Fanchin R, Dubost G, Colau JC, Bremont-Weil C, et al. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online. 2010;2:553–8.CrossRef
31.
Loverro G, Resta L, Dellino M, Edoardo DN, Cascarano MA, Loverro M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol. 2016;55:686–91.CrossRef
32.
Chen D, Simons L. Ethical considerations in fertility preservation for transgender youth: a case illustration. Clin Pract Pediatr Psychol. 2018;6:93–100.CrossRef
33.
Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod BioMed Online. 2005;11:300–8.CrossRef
34.
Chen D, Simons L, Johnson EK, Lockart BA, Finlayson C. Fertility preservation for transgender adolescents. J Adolesc Health. 2017;61:120–3.CrossRef
35.
Nahata L, Tishelman AC, Caltabellotta NM, Quinn GP. Low fertility preservation utilization among transgender youth. J Adolesc Health. 2017;61:40–4.CrossRef
36.
Strang JF, Jarin J, Call D, Clark B, Wallace GL, Anthony LG, et al. Transgender youth fertility attitudes questionnaire: measure development in nonautistic and autistic transgender youth and their parents. J Adolesc Health. 2018;62:128–35.CrossRef
37.
Duncan FE. Egg quality during the pubertal transition-is youth all it’s cracked up to be? Front Endocrinol (Lausanne). 2017;8:226.CrossRef
38.
Zheng W, Zhang H, Gorre N, Risal S, Shen Y, Liu K. Two classes of ovarian primordial follicles exhibit distinct developmental dynamics and physiological functions. Hum Mol Genet. 2014;23:920–8.CrossRef
39.
Maxwell S, Noyes N, Keefe D, Berkeley AS, Goldman KN. Pregnancy outcomes after fertility preservation in transgender men. Obstet Gynecol. 2017;
40.
Cauffman E, Steinberg L. (Im) maturity of judgment in adolescence: why adolescents may be less culpable than adults. Behav Sci Law. 2000;18:741–60.CrossRef
41.
Campo-Engelstein L, Chen D. Ethical issues in pediatric and adolescent fertility preservation. In: TK Woodruff, YC Gosiengfiao, editors. Pediatric and adolescent oncofertility. Cham: Springer; 2017. p. 259–67.CrossRef
42.
Shetty P. India’s unregulated surrogacy industry. Lancet. 2012;380:1633–4.CrossRef
Metadata
Title
Oocyte cryopreservation among transmasculine youth: a case series
Authors
Diane Chen
Lia A. Bernardi
Mary Ellen Pavone
Eve C. Feinberg
Molly B. Moravek
Publication date
01-11-2018
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 11/2018
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1292-4

Other articles of this Issue 11/2018

Journal of Assisted Reproduction and Genetics 11/2018 Go to the issue

Assisted Reproduction Technologies

Perinatal follow-up of children born after preimplantation genetic diagnosis between 1995 and 2014

Assisted Reproduction Technologies

Ten pathways to elective egg freezing: a binational analysis

Reproductive Physiology and Disease

Sperm lipidic profiles differ significantly between ejaculates resulting in pregnancy or not following intracytoplasmic sperm injection

Assisted Reproduction Technologies

Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data

Letter to the Editor

Response from the authors re: Letter to the Editor for our manuscript “The cost of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): a counseling tool”

Fertility Preservation

Delayed childbearing and female ageing impair assisted reproductive technology outcome in survivors of male haematological cancers